<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药春秋 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-16T23:12:26+08:00</updated>
  <subtitle>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>医保谈判第三天，关于PD-1的“搏杀”！</title>
    <updated>2020-12-16T23:11:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/xxSyXs8H8WF3hmkdQz_TiA</id>
    <link href="https://mp.weixin.qq.com/s/xxSyXs8H8WF3hmkdQz_TiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CPHI，药春秋E3B11，来呀~</title>
    <updated>2020-12-16T23:11:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/sl75vg6aXblNw39HcyUfaw</id>
    <link href="https://mp.weixin.qq.com/s/sl75vg6aXblNw39HcyUfaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判第二天，又有什么消息？</title>
    <updated>2020-12-15T23:21:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/7z1w-nTtanf9rsCBqM1u2w</id>
    <link href="https://mp.weixin.qq.com/s/7z1w-nTtanf9rsCBqM1u2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CPHI，药春秋E3B11，来呀~</title>
    <updated>2020-12-15T23:21:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/7d1ZyuYHCxlFRIgyyjLnNA</id>
    <link href="https://mp.weixin.qq.com/s/7d1ZyuYHCxlFRIgyyjLnNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>500亿降脂药市场，集采“肆虐”后，他汀类产品处境如何？</title>
    <updated>2020-12-14T21:38:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/04ZCh_2KAdbcay8RufDtlQ</id>
    <link href="https://mp.weixin.qq.com/s/04ZCh_2KAdbcay8RufDtlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>挡不住的封神之路，降糖“神药”再现新作用！</title>
    <updated>2020-12-14T21:38:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/9iiTyBvbjnP2OnrqaIiGnQ</id>
    <link href="https://mp.weixin.qq.com/s/9iiTyBvbjnP2OnrqaIiGnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今天！超300个药品有望进入国谈</title>
    <updated>2020-12-14T21:38:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/vn841sAucDSuzQMfibOnww</id>
    <link href="https://mp.weixin.qq.com/s/vn841sAucDSuzQMfibOnww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CPhI-China，来了！（附：展商列表）</title>
    <updated>2020-12-14T21:38:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/BOlF0-KjB_6sd1ixvddy0Q</id>
    <link href="https://mp.weixin.qq.com/s/BOlF0-KjB_6sd1ixvddy0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>瑞典多肽类药物供应商，和它的新技术！</title>
    <updated>2020-12-13T19:14:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/CBOWRWTESLy3ohBc2Ajiog</id>
    <link href="https://mp.weixin.qq.com/s/CBOWRWTESLy3ohBc2Ajiog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国FDA批准辉瑞-BioNTech新冠疫苗，紧急授权使用！</title>
    <updated>2020-12-13T19:14:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/f9e73mYIqSQrN3o-V0KTVA</id>
    <link href="https://mp.weixin.qq.com/s/f9e73mYIqSQrN3o-V0KTVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CPhI-China，来了！（附：展商列表）</title>
    <updated>2020-12-12T21:38:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/v8_BTg7sJYRNbNPG3Cj2rA</id>
    <link href="https://mp.weixin.qq.com/s/v8_BTg7sJYRNbNPG3Cj2rA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DPP-4的领军品种-西格列汀（A）</title>
    <updated>2020-12-12T21:38:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/nDTn1dtw3AeWXBXpgiF07A</id>
    <link href="https://mp.weixin.qq.com/s/nDTn1dtw3AeWXBXpgiF07A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>（2020.12.11）最新一致性评价名单到来！</title>
    <updated>2020-12-11T21:51:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/2_ozhXLDii_NI1pTTr4cVQ</id>
    <link href="https://mp.weixin.qq.com/s/2_ozhXLDii_NI1pTTr4cVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明天！第四批国采，开始报量“摸底”</title>
    <updated>2020-12-11T21:51:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/yBQxAQYNTfO4I3FJ5TL2gg</id>
    <link href="https://mp.weixin.qq.com/s/yBQxAQYNTfO4I3FJ5TL2gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新发布：药品研发与技术评审管理新办法</title>
    <updated>2020-12-11T21:51:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/FcEZ-lr0xBocEAyZOxI6OQ</id>
    <link href="https://mp.weixin.qq.com/s/FcEZ-lr0xBocEAyZOxI6OQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保谈判，PD-1成竞争焦点！</title>
    <updated>2020-12-11T21:51:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/iXZ70sm02KPE0ATy5VkJ-Q</id>
    <link href="https://mp.weixin.qq.com/s/iXZ70sm02KPE0ATy5VkJ-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗抑郁潜力大赛道，本土企业早已加速冲线！</title>
    <updated>2020-12-10T21:50:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/4xZ51qdOD1s3gQChauL-ig</id>
    <link href="https://mp.weixin.qq.com/s/4xZ51qdOD1s3gQChauL-ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>5个国采未中选药调整价格</title>
    <updated>2020-12-10T21:50:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/1uHYoIOvfikJC84zTVBJ6Q</id>
    <link href="https://mp.weixin.qq.com/s/1uHYoIOvfikJC84zTVBJ6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官宣！两款临床常用药转OTC</title>
    <updated>2020-12-10T21:50:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/3qcTOy63MQ-NXFChZNa82w</id>
    <link href="https://mp.weixin.qq.com/s/3qcTOy63MQ-NXFChZNa82w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专利期满，国内仿制闻风而至，重磅西那卡塞能否再创佳绩？</title>
    <updated>2020-12-09T21:47:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Gqu11vOlIErKSvL_uawW7Q</id>
    <link href="https://mp.weixin.qq.com/s/Gqu11vOlIErKSvL_uawW7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>